Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Bengt I. Eriksson, Lars C. Borris, Richard J. Friedman et al. · New England Journal of Medicine · 2008 · 1.4K citations · Full text

Medicine, Orthopaedic Surgery, Pharmacology +15

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Michael R. Lassen, Walter Ageno, Lars C. Borris et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

Ajay K. Kakkar, Benjamin Brenner, Ola E. Dahl et al. · The Lancet · 2008 · 1.1K citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Alexander GG Turpie, Michael R. Lassen, Bruce L. Davidson et al. · The Lancet · 2009 · 979 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

Michael E. Nesheim, J.B. Taswell, Kenneth G. Mann · Journal of Biological Chemistry · 1979 · 588 citations · Full text

Medicine, Biochemistry, Molecular Biology +14